Advanced Health Intelligence Ltd
Change company Symbol lookup
Select an option...
AHI Advanced Health Intelligence Ltd
SNTG Sentage Holdings Inc
MDGS Medigus Ltd
WLDS Wearable Devices Ltd
UP Wheels Up Experience Inc
BRTX BioRestorative Therapies Inc
FRZA Forza X1 Inc
ILMN Illumina Inc
NR Newpark Resources Inc
CGC Canopy Growth Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Technology | Small Cap Blend
Based in Australia
Company profile

Advanced Human Imaging Limited is an Australia-based human imaging company. The Company offers a smartphone-based human scanning technology, with a range of data-driven applications across multiple industries. It has developed a dimensioning technology that enables its partners and their users to check, track, and assess their vital signs and dimensions using only a smartphone. Its CompleteScan platform is a multi-scan technology for its partner's smartphone application users. Its BodyScan technology is an image processing technique that returns body circumference, body composition, health risks, and risk indicators. Its FaceScan technology is a non-intrusive method for measuring vital signs, and risks associated with cardiovascular disease, heart attack and stroke. Its DermaScan technology is an intelligent, instant dermatological scanner with diagnostic capabilities, capable of screening for over 500 skin conditions. The Company offers its solutions to various industries.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
1.87 (603.23%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Tesla stock extends bounce, as Morgan Stanley sees 'attractive entry point'

2:11 pm ET December 29, 2022 (MarketWatch)

By Tomi Kilgore

EV maker is in position to boost its lead versus competitors in 2023, analyst Adam Jonas says

Shares of Tesla Inc. charged higher Thursday, to extend their bounce off a more-than two-year low, after Morgan Stanley said the recent sharp selloff has created an attractive opportunity to invest in the electric vehicle market leader.

The stock (TSLA) surged 5.7% in afternoon trading, after rising 3.3% on Wednesday. The bounce comes after the stock plunged 30.8% amid a seven-day losing streak, creating a deeply oversold technical condition, as it closed Tuesday at the lowest price since August 2020.

Even with the bounce, Tesla shares have still plunged 38.8% in December, putting them on track to suffer the biggest monthly drop since they went public in 2010.

Also read: Musk reportedly tells Tesla employees: 'Don't be too bothered by stock-market craziness.'

Morgan Stanley analyst Adam Jonas said he believes the selloff was a result of increasingly unfavorable supply-versus-demand dynamics in the EV market, exacerbated by "technical factors."

"We believe 2023 is shaping up to be a 'reset' year for the EV market where the last 2 years of demand exceeding supply will be substantially inverted to supply exceeding demand," Jonas wrote in a note to clients.

It's within this environment, however, that Jonas believes Tesla can thrive. He believes players who are self-funded with demonstrated scale and relatively low costs throughout the supply chain, like Tesla, can be relative winners.

He reiterated the overweight rating he's had on Tesla since November 2020, saying the stock's selloff amid EV industry concerns has created an "attractive entry point," particularly relative to its competition.

"Between a worsening macro backdrop, record high unaffordability and increasing competition, there are hurdles to overcome," Jonas wrote. "Yet we do believe that in the face of all these pressures, [Tesla] will widen its lead in the EV race, as it leverages its cost and scale advantages to further itself from the competition."

Tesla is expected to outperform rivals, both legacy and start-ups, even before consideration of U.S. Inflation Reduction Act's (IRAs) tax credits, where Tesla also stands out as the biggest potential winner, after they take effect Jan. 1.

Still, Jonas cut his price target on Tesla's stock to $250 from $330, to reflect the market's recent "de-rating" of EV makers.

Tesla's stock has plunged 66.2% year to date, and was headed for the first yearly loss in seven years, and biggest yearly loss on record. In comparison, shares of Fisker Inc. (FSR) have sunk 56.0% this year, General Motors Co. (GM) have dropped 43.1%, Ford Motor Co. (F) have slumped 44.8% and the S&P 500 index has slid 19.2%.

-Tomi Kilgore


(END) Dow Jones Newswires

December 29, 2022 14:11 ET (19:11 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.